Navigation Links
Access Highlighted in Recent BusinessWeek Article
Date:9/11/2007

execution of a definitive merger agreement to acquire Somanta. The acquisition of Somanta has not yet closed and the closing is subject to numerous closing conditions. For additional information on Access Pharmaceuticals, please visit our website at http://www.accesspharma.com

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: Access' plans to initiate clinical trials, the value of its products in the market, its ability to achieve clinical and commercial success, its ability to successfully develop marketed products and the ability to obtain or meet the closing conditions in the merger agreement with Somanta Pharmaceuticals, Inc. and applicable regulatory and tax requirements, and to otherwise complete the merger in a timely manner, yet there can be no assurances that the closing conditions will be met or waived or that the transaction will close. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing and to the risks detailed in Access' and Somanta's Annual Reports on Form 10-KSB and other reports filed by Access and Somanta with the Securities and Exchange Commission.


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Research explains why women lack equal access to angel capital
2. Abbott vs. Thailand has implications for innovation and access
3. More access points for Madison wireless
4. GE partner allows real-time access to patient data
5. Broadband access needs a champion, FCC commissioner says
6. UW Trace center makes sending packages accessible to all
7. Green Bay area businesses ramp up wireless access
8. GE Healthcare, MobileAccess to collaborate on hospital wireless
9. Stem-cell debate, wireless access and other endeavors heat up
10. Computer access brings more Wisconsinites to libraries
11. Promega to get early access to WARF technologies under new agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... Corporation (Nasdaq: DNDN ) announced today that ... have exercised in full their option to purchase ... the public offering price of $24.75 per share. ... size of the offering to an aggregate of ... to receive net proceeds from the offering of ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer ... center in the,US, the Tulane Cancer Center, ... phase III clinical study of Alpharadin in ... cancer,(CRPC) that has metastasized to the skeleton. ... (ALpharadin in SYMptomatic Prostate CAncer) study is ...
(Date:12/10/2009)... (Nasdaq: DNDN ) announced today that it has ... its common stock at a price to the public ... the underwriters a 30-day option to purchase up to ... overallotments, if any. The offering is expected to ... conditions. ,, J. P. Morgan Securities Inc. and Deutsche ...
(Date:12/10/2009)... NEWCASTLE, United Kingdom, Dec. 10 ... North East England Stem Cell Institute (NESCI) ... first successful treatment of eight patients with ... patients, own stem cells without the need ... http://www.newscom.com/cgi-bin/prnh/20080422/CLTU133LOGO-a ) ,, LSCD is a ...
Breaking Biology Technology:Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3Successful Stem Cell Therapy for Treatment of Eye Disease 2Successful Stem Cell Therapy for Treatment of Eye Disease 3Successful Stem Cell Therapy for Treatment of Eye Disease 4
(Date:12/11/2009)... studying how bacteria under stress collectively weigh and initiate ... into how humans make strategic decisions that affect their ... , Their study, published this week in the early ... National Academy of Sciences , was accomplished when the ... describe the complex interplay of genes and proteins that ...
(Date:12/11/2009)... an associate professor of anthropology at the University of ... Kenya to understand how violence shapes the health of ... of her and her colleagues, research," Documenting the health ... northern Kenya: A conceptual framework," is currently published in ... , in collaboration with the British medical journal the ...
(Date:12/11/2009)... Arno Motulsky, the senior editor of the 4th edition ... Human Genetics, was recently given the Victor A. McKusick ... contributions to the field of human genetics, was presented ... American Society of Human Genetics on 24 October 2009 ... Medicine and Genome Sciences at the University of Washington ...
Breaking Biology News(10 mins):Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5UA-led study grapples with health effects of low-intensity warfare 2Mapping the Link Between Alcohol Cancer 60159 1Mapping the Link Between Alcohol Cancer 60159 2Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 1Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 2Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 3Dr Lawrence Brown Named President of the Child Neurology Foundation 60155 1Dr Lawrence Brown Named President of the Child Neurology Foundation 60155 2
... WALNUT CREEK, Calif. The U.S. Department of Energy Joint ... assembly of the soybean (Glycine max) genetic code, making ... new breeding strategies for one of the world,s most ... 70 percent of the world,s edible protein, but also ...
... 8, 2008 Animal feeding operations are an important ... carbon dioxideknown greenhouse gases. Recent inventories suggest that ... methane emissions. As a consequence, greenhouse gas emissions ... development and sustainability of animal production and technologies ...
... help clear the plaques in the brain associated with Alzheimer,s ... The plaques are known to lead to the progressive death ... of dementia. , Sodium valproate - which is marketed as ... at the University of Leeds to reactivate the body,s own ...
Other Biology News:DOE Joint Genome Institute completes soybean genome 2DOE Joint Genome Institute completes soybean genome 3Oil spray reduces greenhouse gas emissions from pig finishing barns 2Epilepsy drug shows potential for Alzheimer's treatment 2
Request Info...
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
Request Info...
Rabbit polyclonal to Glutathione S Transferase alpha ( Abpromise for all tested applications). Antigen: Full length protein: Human Glutathione S Transferase alpha. Entrez GeneID: 2938 Swi...
Biology Products: